Patent · US Active

Substituted pyrazolo[1,5-a]pyrimidines for modulating CDK9 activity

US11845754B2 · kind B2 · utility

0Cited by

18References

11Claims

0Family size

Assignee

Kronos Bio, Inc. · US

Inventors

Peter Mikochik · Groton, US
Joseph P. Vacca · Telford, US
David Freeman · Waltham, US
Andrew Tasker · Simi Valley, US

Key dates

Filing date	Sep 15, 2021
Grant date	Dec 19, 2023
Priority date	—
Expiry date	Nov 16, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Inhibitors of CDK9 that are pyrazolo[1,5-a]pyrimidine derivatives and salts thereof, corresponding to formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.